Top ▲
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 3 | 334 | 11q13.5 | MOGAT2 | monoacylglycerol O-acyltransferase 2 | 3 |
Mouse | 2 | 334 | 7 E1 | Mogat2 | monoacylglycerol O-acyltransferase 2 | 2 |
Rat | - | 334 | 1q32 | Mogat2 | monoacylglycerol O-acyltransferase 2 |
Previous and Unofficial Names ![]() |
DGAT2L5 | MGAT2 |
Database Links ![]() |
|
Alphafold | Q3SYC2 (Hs), Q80W94 (Mm) |
BRENDA | 2.3.1.22 |
ChEMBL Target | CHEMBL2439944 (Hs), CHEMBL3603729 (Mm) |
Ensembl Gene | ENSG00000166391 (Hs), ENSMUSG00000052396 (Mm), ENSRNOG00000027228 (Rn) |
Entrez Gene | 80168 (Hs), 233549 (Mm), 681211 (Rn) |
Human Protein Atlas | ENSG00000166391 (Hs) |
KEGG Enzyme | 2.3.1.22 |
KEGG Gene | hsa:80168 (Hs), mmu:233549 (Mm), rno:681211 (Rn) |
OMIM | 610270 (Hs) |
Pharos | Q3SYC2 (Hs) |
RefSeq Nucleotide | NM_025098 (Hs), NM_177448 (Mm), NM_001109436 (Rn) |
RefSeq Protein | NP_079374 (Hs), NP_803231 (Mm), NP_001102906 (Rn) |
UniProtKB | Q3SYC2 (Hs), Q80W94 (Mm) |
Wikipedia | MOGAT2 (Hs) |
Enzyme Reaction ![]() |
||||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Tissue Distribution ![]() |
||||||||
|
Physiological Consequences of Altering Gene Expression ![]() |
||||||||||
|
General Comments |
Results from genetic studies in mice [1,6-7] suggest that pharmacoligical inhibition of MOGAT2 may be a useful strategy for controlling metabolic disorders induced by high-fat diet. |
1. Banh T, Nelson DW, Gao Y, Huang TN, Yen MI, Yen CL. (2015) Adult-onset deficiency of acyl CoA:monoacylglycerol acyltransferase 2 protects mice from diet-induced obesity and glucose intolerance. J Lipid Res, 56 (2): 379-89. [PMID:25535286]
2. Cao J, Lockwood J, Burn P, Shi Y. (2003) Cloning and functional characterization of a mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2. J Biol Chem, 278 (16): 13860-6. [PMID:12576479]
3. Lockwood JF, Cao J, Burn P, Shi Y. (2003) Human intestinal monoacylglycerol acyltransferase: differential features in tissue expression and activity. Am J Physiol Endocrinol Metab, 285 (5): E927-37. [PMID:12824082]
4. Manganaro F, Kuksis A. (1985) Purification and preliminary characterization of 2-monoacylglycerol acyltransferase from rat intestinal villus cells. Can J Biochem Cell Biol, 63 (5): 341-7. [PMID:4016575]
5. Meng W, Brigance R, Mignone J, Negash L, Zhao G, Ahmad S, Wang W, Moore F, Ye XY, Sun JH et al.. (2023) Discovery of 12 (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders. J Med Chem, 66 (18): 13135-13147. [PMID:37724542]
6. Nelson DW, Gao Y, Spencer NM, Banh T, Yen CL. (2011) Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain. J Lipid Res, 52 (9): 1723-32. [PMID:21734185]
7. Nelson DW, Gao Y, Yen MI, Yen CL. (2014) Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance. J Biol Chem, 289 (25): 17338-49. [PMID:24784138]
8. Turdi H, Chao H, Hangeland JJ, Ahmad S, Meng W, Brigance R, Zhao G, Wang W, Moore F, Ye XY et al.. (2021) Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders. J Med Chem, 64 (19): 14773-14792. [PMID:34613725]
2.3.1.- Acyltransferases: monoacylglycerol O-acyltransferase 2. Last modified on 23/10/2023. Accessed on 30/04/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2881.